These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 9814446)

  • 21. Graves' disease by any other name?
    Weetman AP
    Thyroid; 2000 Dec; 10(12):1071-2. PubMed ID: 11201851
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of methimazole with or without exogenous L-thyroxine on serum concentrations of thyrotropin (TSH) receptor antibodies in patients with Graves' disease.
    Rittmaster RS; Zwicker H; Abbott EC; Douglas R; Givner ML; Gupta MK; Lehmann L; Reddy S; Salisbury SR; Shlossberg AH; Tan MH; York SE
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3283-8. PubMed ID: 8784084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Graves' disease: evolution and prognosis after eight months of treatment with methimazole.
    Gauna AT; Guillén CE; Sartorio GC; Soto RJ
    Medicina (B Aires); 1992; 52(3):207-12. PubMed ID: 1364158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Increased levels of auto-antibodies in thyroid diagnostics: Hashimoto thyroidities or Graves disease?].
    Paschke R
    Internist (Berl); 2006 Nov; 47(11):1193-4. PubMed ID: 17043781
    [No Abstract]   [Full Text] [Related]  

  • 25. A change from stimulatory to blocking antibody activity in Graves' disease during pregnancy.
    Kung AW; Jones BM
    J Clin Endocrinol Metab; 1998 Feb; 83(2):514-8. PubMed ID: 9467567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of TSH receptor antibodies in the management of Graves' disease.
    Matthews DC; Syed AA
    Eur J Intern Med; 2011 Jun; 22(3):213-6. PubMed ID: 21570635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Direct binding of thyrotropin receptor autoantibody to in vitro translated thyrotropin receptor: a comparison to radioreceptor assay and thyroid stimulating bioassay.
    Morgenthaler NG; Hodak K; Seissler J; Steinbrenner H; Pampel I; Gupta M; McGregor AM; Scherbaum WA; Banga JP
    Thyroid; 1999 May; 9(5):466-75. PubMed ID: 10365678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The prognostic value of thyroid stimulating antibodies after antithyroid drug treatment of Graves' disease].
    Li J; Gao H; Xu L
    Zhonghua Yi Xue Za Zhi; 1994 Apr; 74(4):218-20, 254-5. PubMed ID: 7922762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Graves disease in pregnancy a risk for the child. Maternal TSH receptor antibodies can cause fetal and neonatal thyrotoxicosis].
    Roos M; Sjöberg O; Axelsson O; Karlsson FA
    Lakartidningen; 2008 Jan 16-22; 105(3):120-4. PubMed ID: 18290505
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical relevance of immunological markers in Graves' disease.
    Mann K; Saller B; Hörmann R
    Exp Clin Endocrinol; 1991 May; 97(2-3):224-30. PubMed ID: 1680726
    [No Abstract]   [Full Text] [Related]  

  • 31. Measurement of stimulating TSH receptor antibodies in sera of patients with Graves' disease by a recombinant TSH receptor bioassay.
    Derwahl M; Schatz H; Bolle B; Pohl A; Meyer K
    Exp Clin Endocrinol; 1992; 100(1-2):75-9. PubMed ID: 1361452
    [No Abstract]   [Full Text] [Related]  

  • 32. [TSH receptor autoantibody: its historical background and interpretation of the data on TSAb, TSBAb and TBII].
    Saito J; Tatsuno I; Iwamoto I
    Nihon Rinsho; 1999 Aug; 57(8):1829-33. PubMed ID: 10483260
    [No Abstract]   [Full Text] [Related]  

  • 33. [The guidelines for the diagnosis and monitoring of endocrine diseases(except of diabetes mellitus)].
    Hashimoto T
    Rinsho Byori; 2003 Jun; 51(6):592-4. PubMed ID: 12884749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Thyrotropin receptor antibodies (TRAb) as a test of surgical treatment effectiveness in Graves-Basedow's diseases].
    Bojarska-Szmygin A; Ciechanek R; Jezierska B; Zaorska-Rajca J
    Pol Merkur Lekarski; 2002 Sep; 13(75):196-9. PubMed ID: 12474569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between CTLA-4 and CD28 molecule expression on T lymphocytes and stimulating and blocking autoantibodies to the TSH-receptor in children with Graves' disease.
    Bossowski A; Stasiak-Barmuta A; Urban M
    Horm Res; 2005; 64(4):189-97. PubMed ID: 16220002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sequential occurrence of thyroid autoantibodies and Graves' disease after immune restoration in severely immunocompromised human immunodeficiency virus-1-infected patients.
    Jubault V; Penfornis A; Schillo F; Hoen B; Izembart M; Timsit J; Kazatchkine MD; Gilquin J; Viard JP
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4254-7. PubMed ID: 11095463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Anti-TSH receptor antibody(TRAb, TBII, TSAb)].
    Amino N; Fujiwara M
    Nihon Rinsho; 2010 Jul; 68 Suppl 7():305-8. PubMed ID: 20960786
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical value of TSH receptor antibodies measurement in patients with Graves' orbitopathy.
    Eckstein A; Esser J; Mann K; Schott M
    Pediatr Endocrinol Rev; 2010 Mar; 7 Suppl 2():198-203. PubMed ID: 20467363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Immunological tests for thyroid disease].
    Ikeda H
    Rinsho Byori; 2003 Feb; Suppl 124():66-9. PubMed ID: 12710034
    [No Abstract]   [Full Text] [Related]  

  • 40. Changes of serum angiotensin-converting enzyme activity during treatment of patients with Graves' disease.
    Lee DS; Chung JK; Cho BY; Koh CS; Lee M
    Korean J Intern Med; 1986 Jan; 1(1):104-12. PubMed ID: 15759385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.